Economic Evaluation of Epoetin Alfa Hexal (Binocrit) Compared to Darbepoetin Alfa (Aranesp) in the Treatment of Chronic Haemodialysis (CKD5) Patients in Germany
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1874
https://www.valueinhealthjournal.com/article/S1098-3015(13)03779-0/fulltext
Title :
Economic Evaluation of Epoetin Alfa Hexal (Binocrit) Compared to Darbepoetin Alfa (Aranesp) in the Treatment of Chronic Haemodialysis (CKD5) Patients in Germany
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03779-0&doi=10.1016/j.jval.2013.08.1874
First page :
A631
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1713